Pratik,
If Asunra does not work to lower your iron load, the combination that Emby suggested is well known to be the best therapy for reducing iron load in thals. For some patients, the Exjade drugs work fine for maintaining an already low iron load but not so well in lowering a high iron load. This is why 40 mg/kg is suggested for patients battling a high iron load, but that can only help patients who can tolerate the higher dose. If you can tolerate that dose (I would suggest splitting it into two and taking it twice daily to reduce side effects and increase efficacy, as it results in a true 24/7 chelation regimen).
Anyone else think that Novartis should reward thalpal for developing and testing the twice a day regimen? If not for parents like Canadian Family, this wouldn't even be a known option. Many patients have managed to stay on Exjade and achieve better results due to splitting the dose and Novartis should be very thankful to thalpal for our efforts in helping patients use their drug.